These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30652947)

  • 81. Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.
    Goodwin AK; Gibson KM; Weerts EM
    Drug Alcohol Depend; 2013 Oct; 132(3):427-33. PubMed ID: 23538206
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comment on "The abrupt cessation of therapeutically administered sodium oxybate (GHB) may cause withdrawal symptoms".
    Zvosec DL; Smith SW
    J Toxicol Clin Toxicol; 2004; 42(1):121-3; author reply 125-7. PubMed ID: 15083950
    [No Abstract]   [Full Text] [Related]  

  • 83. Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal.
    Nimmerrichter AA; Walter H; Gutierrez-Lobos KE; Lesch OM
    Alcohol Alcohol; 2002; 37(1):67-73. PubMed ID: 11825860
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A web-based study of gamma hydroxybutyrate (GHB): patterns, experiences, and functions of use.
    Stein LA; Lebeau R; Clair M; Martin R; Bryant M; Storti S; Monti P
    Am J Addict; 2011; 20(1):30-9. PubMed ID: 21175918
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.
    Kamal RM; Schellekens A; De Jong CA; Dijkstra BA
    BMC Psychiatry; 2015 Apr; 15():91. PubMed ID: 25927622
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.
    Barker JC; Harris SL; Dyer JE
    J Psychoactive Drugs; 2007 Jun; 39(2):115-29. PubMed ID: 17703706
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.
    Beurmanjer H; Asperslag EM; Oliemeulen L; Goudriaan AE; De Jong CAJ; Schellekens ASA; Dijkstra BAG
    Eur Addict Res; 2019; 25(5):248-255. PubMed ID: 31163444
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB).
    Sumnall HR; Woolfall K; Edwards S; Cole JC; Beynon CM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):286-90. PubMed ID: 17766059
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons.
    Weerts EM; Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM
    Psychopharmacology (Berl); 2005 May; 179(3):678-87. PubMed ID: 15645222
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-Hydroxybutyrate.
    White CM
    J Clin Pharmacol; 2017 Jan; 57(1):33-39. PubMed ID: 27198055
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
    Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
    Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
    Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
    Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication.
    Ferrara SD; Tedeschi L; Frison G; Rossi A
    J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Recreational use of GHB and prescribed drugs: the challenge in forensic and clinical toxicology.
    Brunetti P; Umani Ronchi F
    Clin Ter; 2021 Sep; 172(5):423-424. PubMed ID: 34625772
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Severe delirium after GHB abuse].
    Sundal EV; Giil LM
    Tidsskr Nor Laegeforen; 2020 Feb; 140(2):. PubMed ID: 32026868
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB.
    Corstens D
    J Forensic Leg Med; 2018 Feb; 54():74-75. PubMed ID: 29328965
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A case of severe withdrawal from gamma-hydroxybutyrate.
    Chin RL
    Ann Emerg Med; 2001 May; 37(5):551-2. PubMed ID: 11326198
    [No Abstract]   [Full Text] [Related]  

  • 100. Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.
    Beurmanjer H; Kamal RM; de Jong CAJ; Dijkstra BAG; Schellekens AFA
    CNS Drugs; 2018 May; 32(5):437-442. PubMed ID: 29651711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.